Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation. PAFIT-3 Investigators. The Propafenone in Atrial Fibrillation Italian Trial. (Q54260524)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation. PAFIT-3 Investigators. The Propafenone in Atrial Fibrillation Italian Trial.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation. PAFIT-3 Investigators. The Propafenone in Atrial Fibrillation Italian Trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

0 references

atrial fibrillation

0 references

0 references

author name string

Bianconi L

1

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

Mennuni M

2

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

language of work or name

0 references

publication date

1 September 1998

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

82

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

5

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

584-588

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

Intravenous digoxin: still the drug of choice for acute termination of atrial fibrillation?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Treatment of atrial fibrillation in a district general hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Efficacy of flecainide for the reversion of acute onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Reversion of atrial fibrillation to sinus rhythm with digitalis therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Clinical course of acute atrial fibrillation treated with rapid digitalization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Intravenous propafenone: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation--a single-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Inefficacy of “therapeutic” serum levels of digoxin in controlling the ventricular rate in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Conversion of recent onset atrial fibrillation with single loading oral dose of propafenone: is in-hospital admission absolutely necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Atrial flutter in patients treated for atrial fibrillation with propafenone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900412-3

7 January 2021

Identifiers

10.1016/S0002-9149(98)00412-3

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/9732884

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54260524&oldid=1371366658"